Methods and Compositions for Rapid Nucleic Acid Library Preparation
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/US2015/049249, filed Sep 9, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,214,798 | Methods and Compositions for Rapid Nucleic Acid Library Preparation In force · High confidence | Twist Bioscience Corporation | In force | High confidence | ||
| US 10,450,562 | Methods and Compositions for Rapid Nucleic Acid Library Preparation In force · High confidence | Twist Bioscience Corporation | In force | High confidence | ||
| US 12,686,863 | Methods and Compositions for Rapid Nucleic Library Preparation In force · High confidence | Twist Bioscience Corporation | In force | High confidence |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.